Comparative molecular characterization of typical and exceptional responders in glioblastoma.

作者: Kristin Wipfler , Adam S. Cornish , Chittibabu Guda

DOI: 10.18632/ONCOTARGET.25420

关键词: Exceptional ResponseInternal medicineDiseaseMedicineBioinformaticsSurvival analysisOncologyBrain tumorDownregulation and upregulationGenePhenotypeCDKN2A

摘要: Glioblastoma (GBM) is the most common and deadliest type of primary brain tumor, with a median survival time only 15 months despite aggressive treatment. Although patients have an extremely poor prognosis, relatively small number survive far beyond time. Investigation these exceptional responders has sparked great deal interest becoming important focus in field cancer research. To investigate molecular differences between typical GBM, comparative analyses somatic mutations, copy number, methylation, gene expression datasets from The Cancer Genome Atlas were performed, results integrated via ontology pathway to assess functional significance differential aberrations. Less severe loss CDKN2A, lower CXCL8, FLG mutations are all associated response. Typical characterized by upregulation NF-κB signaling pro-inflammatory cytokines, while Alzheimer's Parkinson's disease pathways as well genes involved synaptic transmission. upregulated processes consistently more tumor phenotypes, those suggest retained ability cells undergo cell death response With upcoming launch National Institute's Exceptional Responders Initiative, similar studies much larger sample sizes will likely become possible, hopefully providing even insight into responders.

参考文章(41)
Jürgen A. Kraus, Nicole Glesmann, Martina Beck, Dietmar Krex, Thomas Klockgether, Gabriele Schackert, Uwe Schlegel, Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme. Journal of Neuro-oncology. ,vol. 48, pp. 89- 94 ,(2000) , 10.1023/A:1006402614838
Jayson I. L. Bastien, Katharine A. McNeill, Howard A. Fine, Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date. Cancer. ,vol. 121, pp. 502- 516 ,(2015) , 10.1002/CNCR.28968
Alexey Kozlenkov, Panos Roussos, Alisa Timashpolsky, Mihaela Barbu, Sergei Rudchenko, Marina Bibikova, Brandy Klotzle, William Byne, Rebecca Lyddon, Antonio Fabio Di Narzo, Yasmin L. Hurd, Eugene V. Koonin, Stella Dracheva, Differences in DNA methylation between human neuronal and glial cells are concentrated in enhancers and non-CpG sites Nucleic Acids Research. ,vol. 42, pp. 109- 127 ,(2014) , 10.1093/NAR/GKT838
Guru Prasad Maiti, Amlan Ghosh, Pinaki Mondal, Aradhita Baral, Sayantan Datta, Sudip Samadder, Sandeep P. Nayak, Jayanta Chakrabarti, Jaydeep Biswas, Nilabja Sikdar, Shantanu Chowdhury, Bidyut Roy, Susanta Roychowdhury, Chinmay Kumar Panda, SNP rs1049430 in the 3'-UTR of SH3GL2 regulates its expression: Clinical and prognostic implications in head and neck squamous cell carcinoma. Biochimica et Biophysica Acta. ,vol. 1852, pp. 1059- 1067 ,(2015) , 10.1016/J.BBADIS.2015.02.009
Y Wu, B P Zhou, TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion British Journal of Cancer. ,vol. 102, pp. 639- 644 ,(2010) , 10.1038/SJ.BJC.6605530
Yassen Assenov, Fabian Müller, Pavlo Lutsik, Jörn Walter, Thomas Lengauer, Christoph Bock, Comprehensive analysis of DNA methylation data with RnBeads Nature Methods. ,vol. 11, pp. 1138- 1140 ,(2014) , 10.1038/NMETH.3115
Y. Jane Tavyev Asher, Fernando Scaglia, Molecular bases and clinical spectrum of early infantile epileptic encephalopathies European Journal of Medical Genetics. ,vol. 55, pp. 299- 306 ,(2012) , 10.1016/J.EJMG.2012.04.002
Janet M. Young, RaeLynn M. Endicott, Sean S. Parghi, Megan Walker, Jeffrey M. Kidd, Barbara J. Trask, Extensive Copy-Number Variation of the Human Olfactory Receptor Gene Family American Journal of Human Genetics. ,vol. 83, pp. 228- 242 ,(2008) , 10.1016/J.AJHG.2008.07.005
Mohammad Shehata, Kaoru Inokuchi, Does autophagy work in synaptic plasticity and memory Reviews in The Neurosciences. ,vol. 25, pp. 543- 557 ,(2014) , 10.1515/REVNEURO-2014-0002
XUAN WANG, LILI JIA, XIAOHUA JIN, QIAN LIU, WEI CAO, XIANGDONG GAO, MINGFENG YANG, BAOLIANG SUN, NF-κB inhibitor reverses temozolomide resistance in human glioma TR/U251 cells Oncology Letters. ,vol. 9, pp. 2586- 2590 ,(2015) , 10.3892/OL.2015.3130